| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A999201 | Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab), Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab), |
|||
| A999202 | Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab), Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab), |
|||
| A999203 | Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR), Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR), |
|||
| A999204 | Anti-TNFRSF18 / GITR / CD357 Reference Antibody (ragifilimab), Anti-TNFRSF18 / GITR / CD357 Reference Antibody (ragifilimab), |
|||
| A999205 | Anti-TNFRSF21 / DR6 / CD358 Reference Antibody (Abbvie patent anti-TNFRSF21), Anti-TNFRSF21 / DR6 / CD358 Reference Antibody (Abbvie patent anti-TNFRSF21), |
|||
| A999206 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (BMS-986178), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (BMS-986178), |
|||
| A999207 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (cudarolimab), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (cudarolimab), |
|||
| A999208 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (ivuxolimab), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (ivuxolimab), |
|||
| A999209 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (revdofilimab), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (revdofilimab), |
|||
| A999210 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (tavolixizumab), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (tavolixizumab), |
|||
| A999211 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (telazorlimab), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (telazorlimab), |
|||
| A999212 | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (vonlerizumab), Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (vonlerizumab), |
|||
| A999213 | Anti-TNFRSF5 / CD40 Reference Antibody (bleselumab), Anti-TNFRSF5 / CD40 Reference Antibody (bleselumab), |
|||
| A999214 | Anti-TNFRSF5 / CD40 Reference Antibody (dacetuzumab), Anti-TNFRSF5 / CD40 Reference Antibody (dacetuzumab), |
|||
| A999215 | Anti-TNFRSF5 / CD40 Reference Antibody (Emory U. anti-CD40), Anti-TNFRSF5 / CD40 Reference Antibody (Emory U. anti-CD40), |
|||
| A999216 | Anti-TNFRSF5 / CD40 Reference Antibody (giloralimab), Anti-TNFRSF5 / CD40 Reference Antibody (giloralimab), |
|||
| A999217 | Anti-TNFRSF5 / CD40 Reference Antibody (iscalimab), Anti-TNFRSF5 / CD40 Reference Antibody (iscalimab), |
|||
| A999218 | Anti-TNFRSF5 / CD40 Reference Antibody (lucatumumab), Anti-TNFRSF5 / CD40 Reference Antibody (lucatumumab), |
|||
| A999219 | Anti-TNFRSF5 / CD40 Reference Antibody (mitazalimab), Anti-TNFRSF5 / CD40 Reference Antibody (mitazalimab), |
|||
| A999220 | Anti-TNFRSF5 / CD40 Reference Antibody (ravagalimab), Anti-TNFRSF5 / CD40 Reference Antibody (ravagalimab), |